Rising PSA following treatment for malignant neoplasm of prostate digital illustration

Rising PSA following treatment for malignant neoplasm of prostate Save


ICD-10 code: R97.21

Disease category: R97.2: Elevated prostate specific antigen [PSA]

Rising PSA following treatment for malignant neoplasm of prostate

Dealing with a rising PSA (prostate-specific antigen) level after treatment for malignant neoplasm of the prostate can be a cause for concern. While it doesn't necessarily indicate a recurrence of cancer, monitoring and understanding the reasons behind the increase are crucial for effective management.

Here are some possible causes for a rising PSA level:

  1. Residual prostate tissue: It is common for small amounts of prostate tissue to remain after surgery or radiation therapy. This benign tissue can still produce PSA, leading to an increase in levels.
  2. Prostatitis: Inflammation of the prostate, known as prostatitis, can cause a temporary spike in PSA levels. This condition is often treated with antibiotics and should be closely monitored.
  3. Benign prostatic hyperplasia: An enlarged prostate, also known as benign prostatic hyperplasia (BPH), can result in elevated PSA levels. This condition is non-cancerous but can cause urinary symptoms that require medical attention.
  4. PSA bounce: After radiation therapy, some men experience a temporary increase in PSA levels. This phenomenon, known as a PSA bounce, does not necessarily indicate cancer recurrence and usually resolves on its own.
  5. Local recurrence or metastasis: Although less common, a rising PSA level can be a sign of cancer recurrence. Further tests, such as imaging studies or biopsies, may be necessary to determine the cause.

It is essential to consult with a healthcare professional to evaluate the situation properly. They will consider various factors, including the rate of PSA rise, previous treatment history, and individual risk factors, to determine the appropriate course of action.

Regular monitoring of PSA levels is crucial to catch any potential changes early. This allows for timely intervention and increased chances of successful treatment. Patients should follow their healthcare provider's recommended schedule for PSA testing and report any concerning symptoms promptly.

Remember, a rising PSA level following treatment for malignant neoplasm of the prostate does not necessarily mean cancer recurrence. By understanding the potential causes and seeking medical guidance, individuals can gain better control over their health and make informed decisions regarding further management.

Treatment of Rising PSA following treatment for malignant neoplasm of prostate:

Treatment Options for Rising PSA following Treatment for Malignant Neoplasm of Prostate

Dealing with a rising prostate-specific antigen (PSA) level after treatment for a malignant neoplasm of the prostate can be a concerning situation. However, there are several treatment options available that can help manage this condition effectively. Here are some commonly recommended approache...

To see full information about treatment please Sign up or Log in